blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2275130

EP2275130 - PCV2 ORF2 immunogenic composition [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.02.2012
Database last updated on 24.04.2024
Most recent event   Tooltip17.02.2012Application deemed to be withdrawnpublished on 21.03.2012  [2012/12]
Applicant(s)For all designated states
BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 North Belt Highway
St. Joseph MO 64506-2002 / US
[2011/03]
Inventor(s)01 / Roof, Michael B.
BOEHRINGER INGELHEIM VETMEDICA, INC. 2621 North Belt Highway
St. Joseph, MO 64506-2002 / US
02 / Eichmeyer, Marc Allan
BOEHRINGER INGELHEIM VETMEDICA, INC. 2621 North Belt Highway
St. Joseph, MO 64506-2002 / US
03 / Nitzel, Greg
BOEHRINGER INGELHEIM VETMEDICA, INC. 2621 North Belt Highway
St. Joseph, MO 64506-2002 / US
04 / Hayes, Phillip Wayne
BOEHRINGER INGELHEIM VETMEDICA, INC. 2621 North Belt highway
St. Joseph, MO 64506-2002 / US
05 / Schaeffer, Merrill Lynn
BOEHRINGER INGELHEIM VETMEDICA, INC. 2621 North Belt highway
St. Joseph, MO 64506-2002 / US
 [2011/03]
Representative(s)Hammann, Heinz, et al
Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2011/03]Hammann, Heinz, et al
Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date10174456.328.12.2006
[2011/03]
Priority number, dateUS20050755016P29.12.2005         Original published format: US 755016 P
US20060829809P17.10.2006         Original published format: US 829809 P
[2011/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2275130
Date:19.01.2011
Language:EN
[2011/03]
Type: A3 Search report 
No.:EP2275130
Date:23.03.2011
[2011/12]
Search report(s)(Supplementary) European search report - dispatched on:EP22.02.2011
ClassificationIPC:A61K39/12
[2011/03]
CPC:
A61K39/12 (EP,KR,US); A61K39/125 (KR); A61P1/04 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P13/12 (EP);
A61P15/00 (EP); A61P17/00 (EP); A61P31/12 (EP);
A61P31/20 (EP); A61P37/00 (EP); A61P37/04 (EP);
A61P7/00 (EP); C12N7/00 (US); A61K2039/5252 (EP,US);
A61K2039/5256 (EP,US); A61K2039/5258 (EP,US); A61K2039/545 (EP,US);
A61K2039/552 (EP,US); A61K2039/55516 (EP,US); A61K2039/55555 (EP,US);
A61K2039/55566 (EP,US); C12N2750/10022 (US); C12N2750/10023 (EP,US);
C12N2750/10034 (EP,US); C12N2750/10051 (EP,US); C12N2750/10071 (US);
C12N2750/14143 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/03]
TitleGerman:PCV2 ORF2 immunogenische Zusammensetzung[2011/03]
English:PCV2 ORF2 immunogenic composition[2011/03]
French:Composé immunofène de PCV2 ORF2[2011/03]
Examination procedure23.09.2011Examination requested  [2011/44]
24.09.2011Application deemed to be withdrawn, date of legal effect  [2012/12]
03.11.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2012/12]
Parent application(s)   TooltipEP06850366.3  / EP1976558
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060850366) is  24.04.2009
Fees paidRenewal fee
30.12.2010Renewal fee patent year 03
30.12.2010Renewal fee patent year 04
03.01.2011Renewal fee patent year 05
02.01.2012Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]WO2006072065  (BOEHRINGER INGELHEIM VETMED [US], et al) [XP] 1-3,5,6,8-11,13-16 * the whole document *;
 [E]WO2007028823  (INTERVET INT BV [NL], et al) [E] 1-16 * the whole document *;
 [XI]  - BLANCHARD P ET AL, "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, ELSEVIER LTD, GB, (20031107), vol. 21, no. 31, doi:10.1016/S0264-410X(03)00503-6, ISSN 0264-410X, pages 4565 - 4575, XP004467337 [X] 1-3,8-11,13-16 * the whole document * [I] 4-7,12

DOI:   http://dx.doi.org/10.1016/S0264-410X(03)00503-6
 [T]  - FACHINGER ET AL, "The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20080301), vol. 26, no. 11, ISSN 0264-410X, pages 1488 - 1499, XP022505432 [T] * the whole document *
 [T]  - KIXMOLLER M ET AL, "Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 26, no. 27-28, ISSN 0264-410X, (20080625), pages 3443 - 3451, (20080505), XP022710551 [T] * the whole document *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2008.04.032
by applicantUS6703023
 US4708871
 US2909462
    - GLENN E. MORRIS,, Epitope Mapping Protocols in Methods in Molecular Biology, HUMANA PRESS, (1996), vol. 66
    - GEYSEN ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 3998 - 4002
    - GEYSEN ET AL., MOLEC. IMMUNOL., (1986), vol. 23, pages 709 - 715
    - BERGMANN ET AL., EUR. J. IMMUNOL., (1993), vol. 23, pages 2777 - 2781
    - BERGMANN ET AL., J. IMMUNOL., (1996), vol. 157, pages 3242 - 3249
    - SUHRBIER, A., IMMUNOL. AND CELL BIOL., (1997), vol. 75, pages 402 - 408
    - CARILLO, H.; LIPMAN, D., SIAM J. APPLIED MATH., (1988), vol. 48, page 1073
    - DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, no. 1, page 387
    - ALTSCHUL, S. F. ET AL., J. MOLEC. BIOL., (1990), vol. 215, pages 403 - 410
    - HUNTER ET AL., The Theory and Practical Application of Adjuvants, JOHNWILEY AND SONS, (1995), pages 51 - 94
    - TODD ET AL., VACCINE, (1997), vol. 15, pages 564 - 570
    - PHAMEUROPA, (199606), vol. 8, no. 2
 US20050034797
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.